LYRA — Lyra Therapeutics Inc

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $0.19 Analyst target: $11.50 Upside: 5952.63%

See the full interactive analysis & chart →

Informational only — not investment advice.